Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 28, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2026
Real World Outcomes of Pembrolizumab and Reduced-Dose Lenvatinib in Recurrent Endometrial Cancer by Platinum and p53 Status.
Journal: Gynecologic oncology reports
Published: November 06, 2025
Association of platinum-based chemotherapy with survival in ovarian carcinosarcoma: a retrospective 2-center cohort study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 22, 2025
Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue.
Journal: Gynecologic oncology
Published: January 03, 2024
The impact of nativity on uterine cancer survival in the public hospital system of Queens, New York.
The impact of nativity on uterine cancer survival in the public hospital system of Queens, New York.
Journal: Gynecologic oncology
Published: October 21, 2023
Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.
Journal: Cold Spring Harbor molecular case studies
Published: July 28, 2023
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma.
Journal: Molecular cancer therapeutics
Published: March 01, 2023
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
Journal: Annals of surgical oncology
Published: February 23, 2023
Engineering and Validation of a Peptide-Stabilized Poly(lactic-co-glycolic) Acid Nanoparticle for Targeted Delivery of a Vascular Disruptive Agent in Cancer Therapy.
Journal: Bioconjugate chemistry
Published: November 11, 2022
Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
Journal: Gynecologic oncology
Published: November 10, 2022
Last Updated: 09/26/2026